Pharmacokinetics of liposome-encapsulated meglumine antimonate after intramuscular and subcutaneous administration in dogs

American Journal of Tropical Medicine and Hygiene

Volumn 57, Issue 4, 1997, Pages 403-406

  Valladares, Josep E ^a   Freixas, Joan ^a   Alberola, Jordi ^a   Franquelo, Carme ^a   Cristofol, Carles ^a   Arboix, Margarita ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

LIPOSOME; MEGLUMINE ANTIMONATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG HALF LIFE; DRUG URINE LEVEL; INTRAMUSCULAR DRUG ADMINISTRATION; LEISHMANIASIS; NONHUMAN; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA; CANIS FAMILIARIS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030875841     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1997.57.403     Document Type: Article

References (24)

1. Herwaldt BL, Berman JD, 1992. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 46: 296-306.
2. Chiang PK, Richards HH, Cantoni GL, 1977. S-adenosyl-L- homocysteine hydrolase: analogues of S-adenosyl-L-homocysteine as potential inhibitors. Mol Pharmacol 13: 939-947.
3. Paolantonacci P, Lawrence F, Lederer F, Robert-Geno M, 1986. Protein methylation and protein methylases in Leishmania donovani and Leishmania tropica promastigotes. Mol Biochem Parasitol 21: 47-54.
4. Avila JL, Avila A, 1987. Correlation of sinefungin susceptibility and drug-affinity for protein carboxymethyl-transferase activity in American Leishmania species. Mol Biochem Parasitol 26: 69-76.
5. Borchardt RT, Keller BT, Patel-Thombre U, 1984. Neplanocin A. A potent inhibitor of S-adenosylhomocysteine hydrolase and of vaccinia virus multiplication in mouse L929 cells. J Biol Chem 259: 4353-4358.
6. Borchardt RT, Keller BT, 1986. Biological methylation and drug design. Borchardt RT, Creveling CR, Ueland PM, eds. Experimental and Clinical Roles of S-adenosyl-Methionine. Clifton, NJ: Humana Press, 385-396.
7. Tseng CKH, Marquez VE, Fuller RW, Goldstein BM, Haines DR, McPhcrson H, Parsons JL, Shannon WM, Arnett G, Holllingshead M, Driscoll JS, 1989. Synthesis of 3-deazaneplanocin A, a powerful inhibitor of S-adenosylhomocysteine hydrolase with potent and selective in vitro and in vivo antiviral activities. J Med Chem 32: 1442-1446.
8. Glazer RI, Knode MC, Tseng CKH, Haines DR, Marquez VE, 1986. 3-Deazaneplanocin A: a new inhibitor of S-adenosylhomocysteine synthesis and its effects in human colon carcinoma cells. Biochem Pharmacol 35: 4523-4527.
9. Glazer RI, Hartman KD, Knode MC, Richard MM, Chiang PK, Tseng CKH, Marquez VE, 1986. 3-Deazaneplanocin A: a new and potent inhibitor of S-adenosylhomocysteine hydrolase and its effects on human promyelocytic leukemia cell line HL-60. Biochem Biophys Res Comm 135: 688-694.
10. Marquez VE, 1996. Carbocyciic nucleosides. Adv Antiviral Drug Design 2: 89-146.
11. Dong Z, Zhu B, Jeffrey AM, 1992. Leishmania donovani: in vitro growth inhibition of promastigotes by a carbocyclic analog of 2′deoxyguanosine. Exp Parasitol 75: 257-258.
12. Henderson DM, Hanson S, Allen T, Wilson K, Coulterkaris DE, Greenberg ML, Hershfield MS, Ullman B, 1992. Cloning of the gene encoding Leishmania donovani S-adenosylhomocy steine hydrolase, a potential target for antiparasitic chemotherapy. Mol Biochem Parasitol 53: 169-183.
13. Da Silva AD, Coimbra ES, Fourrey J-L, Machado AS, Robert- Gero M, 1993. Expeditious enantioselective synthesis of carbocyclic nucleosides with antileishmanial activity. Tetrahedron Lett 34: 6745-6748.
14. Avila JL, Bretana A, Casanova MA, Avila A, Rodriguez F, 1979. Trypanosoma cruzi: defined medium for continuous cultivation of virulent parasites. Exp Parasitol 48: 27-35.
15. Avila JL, Avila A, Polegre MA, 1993. Inhibitory effects of sinefungin and its cyclic analog on the multiplication of Trypanasoma cruzi isolates. Am J Trop Med Hyg 48: 112- 119.
16. Rojas T, Avila JL, 1987. American Leishmania spp: formycin B treatment of cutaneous leishmaniasis in mice. Parasitalagy 94: 467-474.
17. Avila JL, Polegre MA, Robins RK, 1986. Action of pyrazolopyrimidine derivatives on Trypanosoma rangeli culture forms. Comp Biochem Physiol 83C: 291-294.
18. Avila JL, Polegre MA, 1993. Uptake and metabolism of S-adenosyl-L-methionine by Leishmania mexicami and Leishmania braziliensis promastigotes. Mol Biochem Parasitol 59: 123-134.
19. Kim I-K, Zhang C-Y, Chiang PK, Cantoni GL, 1983. S-adenosylhomocysteine hydrolase from hamster liver: purification and kinetic properties. Arch Biochem Biophys 226: 65-72.
20. Berman JD, Dwyer DM, Wyler DJ, 1979. Multiplication of Leishmania in human macrophages in vitro. Infect Immun 26: 375-379.
21. Avila JL, Biondo F, Monzon H, Convit J, 1982. Cutaneous leishmaniasis in mice: resistance to glucan immunotherapy, either alone or combined with chemotherapy. Am J Trop Med Hyg 31: 53-59.
22. Avila JL, Rojas T, Monzon H, Convit J, 1990. Sinefungin as treatment for American Leishmania in sensitive BALB/c and resistant C57B1/6 mice. Am J Trop Med Hyg 43: 139-145.
23. Yarletl N, Bacchi CJ, 1988. Effect of DL-α-difluoro-methylornithine on methionine cycle intermediates in Trypanosoma brucei britcei. Mol Biochem Parasitol 27: 1-10.
24. De Clercq E, Cools M, Balzarini J, Marquez VE, Borcherding DR, Borchardt RT, Drach JC, Kitaoka S, Konno T, 1989. Broad-spectrum antiviral activities of neplanocin A, 3-deazaneplanocin A, and their 5′-nor derivatives. Antimicrob Agents Chemother 33: 1291-1297.